Hudson Bay Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.1M | Buy |
974,776
+304,774
| +45% | +$17.8M | 0.33% | 94 |
|
|
2025
Q4 | $39.8M | Sell |
670,002
-23,892
| -3% | -$1.3M | 0.23% | 141 |
|
|
2025
Q3 | $37.6M | Buy |
693,894
+167,474
| +32% | +$9.58M | 0.23% | 141 |
|
|
2025
Q2 | $28.9M | Sell |
526,420
-60,425
| -10% | -$3.56M | 0.19% | 161 |
|
|
2025
Q1 | $41.5M | Buy |
586,845
+126,845
| +28% | +$8.53M | 0.26% | 152 |
|
|
2024
Q4 | $30.2M | Buy |
460,000
+18,800
| +4% | +$1.26M | 0.18% | 190 |
|
|
2024
Q3 | $31M | Buy |
441,200
+196,500
| +80% | +$16.4M | 0.21% | 123 |
|
|
2024
Q2 | $20.1M | Buy |
244,700
+134,800
| +123% | +$11.2M | 0.15% | 139 |
|
|
2024
Q1 | $9.6M | Buy |
109,900
+35,287
| +47% | +$3.16M | 0.08% | 178 |
|
|
2023
Q4 | $7.19M | Sell |
74,613
-56,297
| -43% | -$4.98M | 0.06% | 243 |
|
|
2023
Q3 | $11.6M | Buy |
130,910
+77,910
| +147% | +$6.93M | 0.11% | 147 |
|
|
2023
Q2 | $4.59M | Buy |
53,000
+23,000
| +77% | +$2.16M | 0.05% | 324 |
|
|
2023
Q1 | $2.92M | Sell |
30,000
-60,000
| -67% | -$6.22M | 0.03% | 445 |
|
|
2022
Q4 | $9.31M | Sell |
90,000
-15,000
| -14% | -$1.41M | 0.11% | 190 |
|
|
2022
Q3 | $8.9M | Sell |
105,000
-35,890
| -25% | -$3.2M | 0.09% | 205 |
|
|
2022
Q2 | $11.7M | Buy |
140,890
+93,390
| +197% | +$7.44M | 0.11% | 152 |
|
|
2022
Q1 | $3.66M | Buy |
47,500
+17,500
| +58% | +$1.46M | 0.05% | 499 |
|
|
2021
Q4 | $2.65M | Sell |
30,000
-70,000
| -70% | -$5.78M | 0.03% | 595 |
|
|
2021
Q3 | $7.73M | Buy |
100,000
+15,000
| +18% | +$1.18M | 0.11% | 198 |
|
|
2021
Q2 | $7.09M | Sell |
85,000
-7,500
| -8% | -$595K | 0.09% | 227 |
|
|
2021
Q1 | $6.99M | Sell |
92,500
-2,500
| -3% | -$204K | 0.1% | 191 |
|
|
2020
Q4 | $8.33M | Buy |
95,000
+43,300
| +84% | +$3.43M | 0.11% | 135 |
|
|
2020
Q3 | $3.93M | Sell |
51,700
-23,300
| -31% | -$2.36M | 0.07% | 271 |
|
|
2020
Q2 | $9.25M | Sell |
75,000
-10,000
| -12% | -$994K | 0.17% | 109 |
|
|
2020
Q1 | $7.18M | Sell |
85,000
-50,000
| -37% | -$4.31M | 0.19% | 104 |
|
|
2019
Q4 | $11.4M | Sell |
135,000
-27,700
| -17% | -$2.09M | 0.28% | 69 |
|
|
2019
Q3 | $11M | Buy |
162,700
+62,700
| +63% | +$4.83M | 0.31% | 61 |
|
|
2019
Q2 | $8.56M | Hold |
100,000
| – | – | 0.24% | 103 |
|
|
2019
Q1 | $8.88M | Sell |
100,000
-10,000
| -9% | -$927K | 0.26% | 166 |
|
|
2018
Q4 | $9.37M | Buy |
110,000
+10,000
| +10% | +$951K | 0.28% | 157 |
|
|
2018
Q3 | $9.7M | Hold |
100,000
| – | – | 0.25% | 153 |
|
|
2018
Q2 | $9.42M | Sell |
100,000
-40,000
| -29% | -$3.5M | 0.27% | 151 |
|
|
2018
Q1 | $11.3M | Buy |
140,000
+30,000
| +27% | +$2.57M | 0.43% | 88 |
|
|
2017
Q4 | $9.81M | Sell |
110,000
-75,500
| -41% | -$6.56M | 0.34% | 80 |
|
|
2017
Q3 | $17.3M | Buy |
185,500
+89,500
| +93% | +$7.91M | 0.69% | 52 |
|
|
2017
Q2 | $8.72M | Sell |
96,000
-64,406
| -40% | -$5.86M | 0.35% | 122 |
|
|
2017
Q1 | $14.1M | Buy |
160,406
+15,000
| +10% | +$1.33M | 0.52% | 108 |
|
|
2016
Q4 | $12M | Sell |
145,406
-49,594
| -25% | -$4.26M | 0.57% | 85 |
|
|
2016
Q3 | $18M | Buy |
195,000
+27,000
| +16% | +$2.54M | 1.11% | 41 |
|
|
2016
Q2 | $13.1M | Buy |
168,000
+78,000
| +87% | +$6.63M | 0.84% | 40 |
|
|
2016
Q1 | $7.42M | Buy |
90,000
+49,500
| +122% | +$4.03M | 0.55% | 43 |
|
|
2015
Q4 | $4.24M | Sell |
40,500
-49,700
| -55% | -$5.19M | 0.33% | 79 |
|
|
2015
Q3 | $9.5M | Sell |
90,200
-37,533
| -29% | -$5.01M | 0.61% | 49 |
|
|
2015
Q2 | $17.5M | Sell |
127,733
-27,267
| -18% | -$3.38M | 0.85% | 45 |
|
|
2015
Q1 | $19.3M | Buy |
+155,000
| New | +$16.4M | 0.78% | 40 |
|
Other funds holding BMRN
VCM
VPM
